Potency determination of factor VIII and factor IX for new product labelling and postinfusion testing: challenges for caregivers and regulators

Publisher： John Wiley & Sons Inc

E-ISSN： 1365-2516|21|4|543-549

ISSN： 1351-8216

Source： HAEMOPHILIA, Vol.21, Iss.4, 2015-07, pp. : 543-549

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

6 Factor VIII Concentrates, Factor VIII/von Willebrand Factor Concentrates, Factor IX Concentrates, Activated Prothrombin Complex Concentrates

By  

Transfusion Medicine and Hemotherapy, Vol. 36, Iss. 6, 2009-12 ,pp. : 409-418

Karger

Access to resources Recommend Favorite

Role of enhanced half‐life factor VIII and IX in the treatment of haemophilia

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 169, Iss. 6, 2015-06 ,pp. : 768-776

John Wiley & Sons Inc

Access to resources Recommend Favorite

Thrombin generation assay using factor XIa to measure factors VIII and IX and their glycoPEGylated derivatives is robust and sensitive

By  

JOURNAL OF THROMBOSIS AND HAEMOSTASIS, Vol. 13, Iss. 11, 2015-11 ,pp. : 2041-2052

John Wiley & Sons Inc

Access to resources Recommend Favorite

Prerequisites for recombinant factor VIIa‐induced thrombin generation in plasmas deficient in factors VIII, IX or XI

By  

JOURNAL OF THROMBOSIS AND HAEMOSTASIS, Vol. 4, Iss. 1, 2006-01 ,pp. : 192-200

John Wiley & Sons Inc

Access to resources Recommend Favorite

Recombinant porcine factor VIII: a new instalment of a long story

By  

HAEMOPHILIA, Vol. 21, Iss. 2, 2015-03 ,pp. : 149-151

John Wiley & Sons Inc

Access to resources Recommend Favorite